Home › Clear-cell metastatic renal cell carcinoma
Pag-aaral pangklinika para sa Clear-cell metastatic renal cell carcinoma na nagre-recruit sa U.S.
17 pag-aaral para sa Clear-cell metastatic renal cell carcinoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Baldwin Park, CA7 pag-aaral
- Dallas, TX5 pag-aaral
- Nashville, TN5 pag-aaral
- New York City, NY5 pag-aaral
- Waukegan, IL4 pag-aaral
- St. Louis, MO4 pag-aaral
- Rochester, MN4 pag-aaral
- Jacksonville, FL3 pag-aaral
- Portland, OR3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Irvine, CA3 pag-aaral
- Boston, MA3 pag-aaral
- Orlando, FL3 pag-aaral
- San Diego, CA3 pag-aaral
- Omaha, NE3 pag-aaral
- Cleveland, OH3 pag-aaral
- Queens, NY3 pag-aaral
- Houston, TX3 pag-aaral
- Philadelphia, PA3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- San Francisco, CA3 pag-aaral
Ayos sa estado
- Arizona4 pag-aaral
- Arkansas3 pag-aaral
- California9 pag-aaral
- Florida4 pag-aaral
- Illinois5 pag-aaral
- Massachusetts4 pag-aaral
- Michigan4 pag-aaral
- Minnesota5 pag-aaral
- Missouri4 pag-aaral
- Nebraska3 pag-aaral
- New Jersey3 pag-aaral
- New York6 pag-aaral
- Ohio3 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania4 pag-aaral
- South Carolina4 pag-aaral
- Tennessee6 pag-aaral
- Texas6 pag-aaral
- Virginia3 pag-aaral
- Washington3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07011719Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07748988Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05361720A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07300241Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06866262Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07179770Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05263050Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07043608Imaging of Solid Tumors Using 18F-TRX
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06942104Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT07128680Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT07383441VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT07510334Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT06349642Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04510597CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update May 30, 2024 · NCT06399419Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.